Abstract
Abstract
Metabolic dysfunction-associated steatotic liver disease (MASLD) affects roughly one third of adults and clusters with obesity, type 2 diabetes and dyslipidaemia (Le et al. 2022; Rinella et al. 202...
Direct answer
What can I do from this paper page?
Use this page to scan "Curcumin in MASLD: a pleiotropic candidate in the era of targeted pharmacotherapy?" quickly: start with the summary and abstract, then check the authors, source, topics, and related papers. From here, open Scollr to follow Curcumin's Biomedical Applications research, save the paper, or map adjacent work.
Research areas
Follow related topics
Citation
BibTeX
@article{Cicero2026Curcumin,
title = {Curcumin in MASLD: a pleiotropic candidate in the era of targeted pharmacotherapy?},
author = {Arrigo F.G. Cicero and Amirhossein Sahebkar},
journal = {Natural Product Research},
year = {2026},
doi = {10.1080/14786419.2026.2752034},
url = {https://doi.org/10.1080/14786419.2026.2752034}
}
FAQ
Using this paper in a discovery workflow
How do I find related work for this paper?
Use the related papers and topic links on this page as starting points. In Scollr, you can also open the paper and build a literature map around its references, citing papers, and related work.
How can I keep up with new Curcumin's Biomedical Applications research papers?
Follow Curcumin's Biomedical Applications research in Scollr. New papers from the topic flow into a personalized feed, and you can save useful studies to revisit later.
Can I cite this paper from this page?
This page includes a static BibTeX block for Curcumin in MASLD: a pleiotropic candidate in the era of targeted pharmacotherapy?. Always verify the DOI, source, and publication details against the publisher record before submitting a manuscript.
Follow this research in Scollr
Follow the topics and authors behind this paper, save useful studies, and build a literature map when you are ready to go deeper.
Get the app